Latest News - Cardinal Health
Top Corporates Hub
Cardinal Health
What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?
08.10.2026 10:11
CVS Health (NYSE:CVS) has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwide pharmacy and retail operations. Management highlighted that the agreements cover prescription drug distribution across CVS Health's retail pharmacies and other dispensing channels. The extension of CVS Health's Cardinal Health and McKesson distribution...
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
06.10.2026 13:30
Eli Lilly's revenue surged 44.7% in 2025, but Novo Nordisk trades at less than a quarter of its valuation multiple, a stark contrast that reshapes the risk-reward calculus.
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
06.10.2026 12:33
CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
06.10.2026 12:08
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 40.7% over the past six months, topping the S&P 500 by 23.9 percentage points.
How Extending CVS Distribution Through 2032 At Cardinal Health (CAH) Has Changed Its Investment Story
05.10.2026 04:25
In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This long‑dated extension reinforces the durability of Cardinal Health’s core distribution relationships, underscoring the importance of scale partnerships in its business model. We’ll now explore how the extended CVS distribution agreement through 2032 may...
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
04.10.2026 14:34
One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability or growth potential.
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
02.10.2026 12:41
Medical-dental supplies see durable demand from specialty care, AI and aging trends, with McKesson and peers navigating tariffs and inflation.
Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032
01.10.2026 12:41
Cardinal Health (NYSE:CAH) has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The extended agreement will maintain the existing scope of distribution services provided by Cardinal Health to CVS Health.
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
01.10.2026 11:56
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
01.10.2026 10:50
Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services.
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
01.10.2026 10:45
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Cardinal Health Affirms FY2027 Adj EPS Of $12.40-$12.60 vs $12.04 Est
01.10.2026 07:26
Cardinal Health (NYSE:CAH) reaffirmed FY2027 Adj EPS of $12.40-$12.60 vs $12.04 analyst estimate.
Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032
01.10.2026 07:00
Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal
Cardinal Health (CAH) Stock Looks About Right At Today’s Price
24.09.2026 17:12
Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a strong multi year run, investors are increasingly focused on what its earnings actually justify. Cardinal Health has returned about 378.2% over the past 5 years, which puts real pressure on the current valuation story to be supported by the earnings profile. The...
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?
24.09.2026 15:45
CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.
Medical Textile Market Global Report 2026: A $39.53 Billion Revenue Surge to $64.28 Billion by 2030 at 26.9% CAGR, Benchmark 3M, Medline Industries, Cardinal Health, and DuPont to Secure Market Share
23.09.2026 10:51
Profiles 3M, Medline, Cardinal Health, Medtronic and DuPont, covering competitors, segments, regional shares, trends and opportunities. Medical Textile Market Medical Textile Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Medical Textile Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. Medical Textile Market to Reach $64.28 Billion by 2030 as Healthcare Demand Accelerates The global medical textile market is experiencing exponential growth, supported by rising
2 Large-Cap Stocks with Solid Fundamentals and 1 We Brush Off
23.09.2026 09:57
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
2 Large-Cap Stocks with Solid Fundamentals and 1 We Brush Off
23.09.2026 09:57
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Cardinal Health Sees Growth Normalize as Specialty, At-Home Investments Expand
19.09.2026 16:02
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company’s fiscal 2026 performance was supported by double-digit earnings growth across each of its five operating segments, while fiscal 2027 guidance reflects continued growth from a more normalized base. Speaking at a Baird event, Hollar said t
2 Cash-Producing Stocks Worth Your Attention and 1 We Ignore
14.09.2026 17:39
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.